Cat. No. 1963
Chemical Name: N-(6,8-Difluoro-2-methyl-4-quinolin
Biological ActivitySelective non-peptide orexin OX1 receptor antagonist (Kb values are 21.7 and 1405 nM for human OX1 and OX2 receptors respectively). Blocks orexin-A induced grooming following oral administration in vivo.
Licensing InformationSold for research purposes under agreement from GlaxoSmithKline
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Langmead et al (2004) Characterisation of the binding of [3H]-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptor. Br.J.Pharmacol. 141 340. PMID: 14691055.
Porter (2001) Advances in novel 7-TM receptors: non-peptide orexin-1 antagonists. Royal Society of Chemistry Meeting..
If you know of a relevant reference for SB 408124 please let us know.
Citations are publications that use Tocris products. Selected citations for SB 408124 include:
Urbałska et al (2012) Orexins/hypocretins acting at Gi protein-coupled OX 2 receptors inhibit cyclic AMP synthesis in the primary neuronal cultures. BMC Cancer 46 42561. PMID: 21547533.
Do you know of a great paper that uses SB 408124 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: SB 408124, supplier, Selective, non-peptide, OX1, antagonists, Orexin1, Receptors, SB408124, GlaxoSmithKline, GSK, Tocris Bioscience, OX1 Receptor Antagonist products
Find multiple products by catalog number
June 14 - 17, 2017
Boston, MA, USA